TY - JOUR
T1 - Nontuberculous mycobacterial infections in children
AU - Bhattacharya, Jyotsna
AU - Mohandas, Sindhu
AU - Goldman, David L.
N1 - Publisher Copyright:
© 2019 American Academy of Pediatrics. All rights reserved.
PY - 2019/4
Y1 - 2019/4
N2 - Based on strong evidence from independent gold standard studies of independent populations, nontuberculous mycobacteria (NTM) disease is acquired from environmental exposures and affects both immunocompetent and immunocompromised children. (15)(20) • Based on strong evidence from independent gold standard studies of independent populations, rapidly growing NTM, which are resistant to a variety of antimycobacterial agents, have become an important cause of skin and soft tissue infections, and outbreaks of disease have been reported in association with medical tourism. Likewise, pulmonary infections due to resistant NTM have become increasingly problematic for patients with CF. (2)(34)(37) • Based on strong evidence from independent gold standard studies of independent populations, advances in molecular biology have led to improved diagnostics, which provide for a timelier diagnosis and allow for differentiation of organisms at the species and subspecies levels. Depending on the host and type of disease, this differentiation may be important in guiding initial therapy before susceptibilities are available. (10)(72)(74) • Based on strong evidence from independent gold standard studies of independent populations, treatment of NTM-associated disease is site specific and should also take into account the immune status of the host and organism susceptibility testing results.(2)(10)(75).
AB - Based on strong evidence from independent gold standard studies of independent populations, nontuberculous mycobacteria (NTM) disease is acquired from environmental exposures and affects both immunocompetent and immunocompromised children. (15)(20) • Based on strong evidence from independent gold standard studies of independent populations, rapidly growing NTM, which are resistant to a variety of antimycobacterial agents, have become an important cause of skin and soft tissue infections, and outbreaks of disease have been reported in association with medical tourism. Likewise, pulmonary infections due to resistant NTM have become increasingly problematic for patients with CF. (2)(34)(37) • Based on strong evidence from independent gold standard studies of independent populations, advances in molecular biology have led to improved diagnostics, which provide for a timelier diagnosis and allow for differentiation of organisms at the species and subspecies levels. Depending on the host and type of disease, this differentiation may be important in guiding initial therapy before susceptibilities are available. (10)(72)(74) • Based on strong evidence from independent gold standard studies of independent populations, treatment of NTM-associated disease is site specific and should also take into account the immune status of the host and organism susceptibility testing results.(2)(10)(75).
UR - http://www.scopus.com/inward/record.url?scp=85064218247&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064218247&partnerID=8YFLogxK
U2 - 10.1542/pir.2018-0131
DO - 10.1542/pir.2018-0131
M3 - Article
C2 - 30936399
AN - SCOPUS:85064218247
SN - 0191-9601
VL - 40
SP - 179
EP - 190
JO - Pediatrics in review
JF - Pediatrics in review
IS - 4
ER -